By Shailesh Khanduri New Delhi Maiden Pharmaceuticals which is under the lens of regulators after the WHO issued an alert saying the firm s cough syrups could potentially be linked to the death of children in The Gambia has its global presence mostly in Africa South America and South East Asia As per its website the company has its corporate office at Pitampura in the National Capital with two manufacturing units in Haryana one at Kundli and another at Panipat It claims to be a WHO GMP ISO certified pharmaceutical company The company had started operations on November Maiden Pharmaceuticals global presence has a strong concentration in Africa including countries such as Algeria Senegal Nigeria Cameroon Kenya and Tanzania In South East Asia also it has presence in countries such as Laos Vietnam Thailand Cambodia the Philippines Malaysia and Indonesia among others The company s footprints in South America include Ecuador Chile Venezuela Surinam and Paraguay besides others It is also present in Russia Poland and Belarus It manufactures a range of products such as capsules injectables syrups ointments and tables across various therapeutic areas The company has an annual production capacity of crore capsules crore injections lakh tubes of ointments lakh syrups and crore tablets according to its website Read more 